We are live on ! Find out more
NEO icon

NeoGenomics

56 hedge funds and large institutions have $59M invested in NeoGenomics in 2013 Q2 according to their latest regulatory filings, with 56 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
+56
Holders Change %
% of All Funds
1.83%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
56
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Fifth Third Bancorp
51
Fifth Third Bancorp
Ohio
$16K +$15.3K +4,000 New
TRCT
52
Tower Research Capital (TRC)
New York
$14K +$13.3K +3,495 New
AllianceBernstein
53
AllianceBernstein
Tennessee
$11K +$11K +2,886 New
Ameriprise
54
Ameriprise
Minnesota
$8K +$7.82K +2,050 New
Barclays
55
Barclays
United Kingdom
$7K +$6.58K +1,726 New
FLC
56
Francis L. Coolidge
$2K +$2.29K +600 New

NEO Hedge Fund Activity: Q2 2013 in Review

56 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q2 2013, worth a combined $59M.

Buyers outnumbered sellers: 56 funds opened new NEO positions and 0 closed out — a net gain of 56 holders — while 0 added to existing stakes and 0 trimmed.

  • 56 institutional investors held NeoGenomics (NEO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $59M of NeoGenomics stock for Q2 2013.
  • 56 funds opened new NeoGenomics positions in Q2 2013 and 0 closed out, a net change of +56 holders.

Based on aggregated 13F filings for Q2 2013.